For stomach cancer, aerosol chemotherapy offers breath of hope
Scientists in France are developing an aerosol chemotherapy for gastric cancer that may help patients avoid side effects like stomach upset and... Read More
Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma
A recent study in patients with metastatic gastric cancer showed that adding docetaxel to a modified FOLFOX7 chemo regimen produced a response... Read More
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases
A study following 277 gastric cancer patients with peritoneal metastases found that cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy improved overall and... Read More
Merck Provides Update on Phase 3 KEYNOTE-062 Trial Evaluating KEYTRUDA
Merck finds Keytruda no better than chemo as a first-line treatment for gastric cancer, according to a Phase 3 study. Results of... Read More
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial
In the randomized, phase II (part 1) ATTRACTION-4 trial, nivolumab combined with chemotherapy [S-1 plus oxaliplatin (SOX) or capecitabine plus oxaliplatin (CapeOX)]... Read More
Comparison of Four Front-Line Doublets in Asian Patients With Metastatic Gastric Cancer
In a Phase II trial, four front-line chemotherapy doublets were compared for treatment of patients with metastatic gastric cancer. While one group... Read More
Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage III gastric cancer
A new study suggests that adding docetaxel to fluoropyrimidine post surgery is effective in stage 3 gastric cancer.
Nutrition for Patients With Mucositis
Dr. Jann Arends discusses the importance of considering nutritional treatment for #cancer patients with mucositis, painful inflammation and ulceration of the mucous... Read More
Perioperative Fluorouracil + Leucovorin, Oxaliplatin, and Docetaxel vs Fluorouracil or Capecitabine + Cisplatin and Epirubicin for Locally Advanced, Resectable Gastric or GE Junction Adenocarcinoma
A phase II/III trial investigated a chemotherapy triplet, FLOT (docetaxel, oxaliplatin, 5-FU/LV), as perioperative therapy in resectable gastroesophageal cancers compared with ECF/ECX,... Read More
Updated Clinical Data from Combination of Margetuximab and Pembrolizumab in Gastric Cancer Presented at 2019 ASCO Gastrointestinal Cancers Symposium
“We continue to be very encouraged by the tolerability and antitumor activity of margetuximab with an anti-PD-1 mAb, an investigational, chemotherapy-free approach... Read More
